CFZS pathophysiology may most closely resemble EMARDD (early onset myopathy, areflexia, respiratory distress, and dysphagia), which results from MEGF10 mutations that appear to reduce myocyte proliferation, differentiation, and fusion32, 33, 34. Here, MEGF10 is linked to myopathy.